Workflow
景顺长城沪深300指数增强A
icon
Search documents
可控核聚变概念涨幅居前,23位基金经理发生任职变动
Jin Rong Jie· 2025-12-11 09:25
Market Performance - On December 11, A-shares saw declines across major indices, with the Shanghai Composite Index down 0.7% to 3873.32 points, the Shenzhen Component Index down 1.27% to 13147.39 points, and the ChiNext Index down 1.41% to 3163.67 points [1] Fund Manager Changes - On December 11, a total of 23 fund managers experienced changes in their positions, with 701 fund products seeing manager departures over the past 30 days [3][4] - The reasons for these changes included 6 managers leaving due to job changes, 2 due to product expiration, and 1 for personal reasons [3] New Fund Managers - On December 11, 33 fund products announced new fund manager appointments, involving 14 new managers [5] - Notably, Liang Pusen from Qianhai Kaiyuan Fund has a total fund asset scale of 36.10 billion yuan, with his highest-performing product being the Qianhai Kaiyuan Gold ETF, which achieved a return of 132.74% over 5 years and 212 days [5] Fund Research Activity - In the past month (November 11 to December 11), Bosera Fund conducted the most company research, engaging with 49 listed companies, followed by Huaxia Fund and Guotai Fund with 45 and 44 companies respectively [7] - The consumer electronics sector was the most researched industry, with 250 instances of fund company inquiries, followed by specialized equipment with 218 inquiries [7] Recent Fund Research Focus - In the last week (December 4 to December 11), Zhongke Shuguang was the most researched company, receiving inquiries from 116 fund institutions, followed by Haiguang Information and Canxin Technology [8][9]
机构风向标 | 新亚强(603155)2025年三季度已披露持仓机构仅3家
Xin Lang Cai Jing· 2025-10-30 03:17
Core Viewpoint - Xin Ya Qiang (603155.SH) reported its Q3 2025 results, highlighting a slight decrease in institutional ownership compared to the previous quarter [1] Institutional Ownership - As of October 29, 2025, three institutional investors disclosed holdings in Xin Ya Qiang A-shares, totaling 65.6456 million shares, which represents 20.79% of the total share capital [1] - The combined institutional ownership decreased by 0.20 percentage points from the previous quarter [1] Public Fund Participation - In this reporting period, seven public funds were disclosed, including major funds such as Morgan Stanley ESG Quantitative Mixed Fund, Invesco Great Wall CSI 300 Index Enhanced A, and several others focused on the CSI 2000 ETF [1] Foreign Investment - The report noted that there were no new disclosures from foreign institutions compared to the previous quarter, specifically mentioning China International Capital Corporation Hong Kong Asset Management Co., Ltd. - CICCFT10(Q) [1]
机构风向标 | 乐惠国际(603076)2025年三季度已披露持仓机构仅3家
Xin Lang Cai Jing· 2025-10-30 01:40
Core Insights - Lehui International (603076.SH) reported its Q3 2025 results on October 30, 2025, highlighting the current institutional investor holdings and changes in share ownership [1] Institutional Holdings - As of October 29, 2025, three institutional investors disclosed holdings in Lehui International A-shares, totaling 34.79 million shares, which represents 28.82% of the company's total share capital [1] - The institutional investors include Ningbo Lehui Investment Holding Co., Ltd., Ningbo Leying Investment Management Center (Limited Partnership), and Ningbo Leili Investment Management Center (Limited Partnership) [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 0.07 percentage points [1] Public Fund Disclosures - In this reporting period, 13 public funds were not disclosed compared to the previous quarter, including notable funds such as China Europe Small Cap Growth Mixed A, Xinyuan National Index 2000 Enhanced A, and others [1]
机构风向标 | 山石网科(688030)2025年三季度已披露前十大机构持股比例合计下跌3.11个百分点
Xin Lang Cai Jing· 2025-10-30 01:35
Group 1 - The core point of the news is that Shanshi Network Technology (688030.SH) reported its Q3 2025 results, revealing significant institutional investor activity with 11 institutions holding a total of 75.54 million shares, representing 41.91% of the total share capital [1] - Among the top ten institutional investors, the combined holding ratio decreased by 3.11 percentage points compared to the previous quarter, indicating a potential shift in investor sentiment [1] - The top ten institutional investors include notable firms such as Shenzhou Cloud Technology, 360 Digital Security Group, and Yixing Guangkong Investment, collectively holding 41.90% of the shares [1] Group 2 - In the public fund sector, two funds increased their holdings compared to the previous period, with a total increase of 0.10% [2] - Two new public funds disclosed their holdings this quarter, including GF SSE Sci-Tech Innovation Board 100 Enhanced Strategy ETF and CITIC Securities CSI 1000 Enhanced A [2] - A total of 80 public funds did not disclose their holdings this quarter, including several notable funds such as Huaxia CSI 500 Enhanced A and Morgan Stanley Multi-Factor Strategy Mixed Fund [2]
机构风向标 | 东珠生态(603359)2025年三季度已披露持仓机构仅4家
Xin Lang Cai Jing· 2025-10-30 01:35
Core Viewpoint - Dongzhu Ecology (603359.SH) reported an increase in institutional ownership, indicating growing interest from institutional investors in the company [1] Institutional Ownership - As of October 29, 2025, four institutional investors disclosed holdings in Dongzhu Ecology A-shares, totaling 5.9245 million shares, which represents 1.33% of the company's total share capital [1] - The institutional ownership increased by 1.32 percentage points compared to the previous quarter [1] Public Fund Activity - One new public fund disclosed its holdings this quarter, namely Huatai Baoxing Jinianhong Mixed Fund [1] - Six public funds were not disclosed in this quarter compared to the previous one, including Southern CSI 2000 ETF, Invesco Great Wall CSI 300 Index Enhanced A, and others [1] Foreign Investment - Two new foreign institutions disclosed their holdings this quarter, including MORGAN STANLEY & CO.INTERNATIONAL PLC. and J.P. Morgan Securities PLC - proprietary funds [1]
机构风向标 | 再升科技(603601)2025年三季度已披露持仓机构仅7家
Xin Lang Cai Jing· 2025-10-29 02:17
Core Viewpoint - Zaiseng Technology (603601.SH) reported its Q3 2025 results, highlighting a notable increase in institutional ownership and changes in public and social security fund holdings [1] Institutional Holdings - As of October 28, 2025, seven institutional investors disclosed holdings in Zaiseng Technology, totaling 99.68 million shares, which represents 9.68% of the company's total equity [1] - The institutional ownership increased by 0.57 percentage points compared to the previous quarter [1] Public Fund Holdings - One new public fund disclosed its holdings in this period, namely Yongying Hejia One-Year Mixed A [1] - A total of 112 public funds were not disclosed in this quarter, including notable funds such as Fortune CSI 300 Index Enhanced A/B and Invesco Great Wall CSI 300 Index Enhanced A [1] Social Security Fund Holdings - One new social security fund disclosed its holdings, which is the National Social Security Fund 503 Portfolio [1] - One social security fund, the National Social Security Fund 412 Portfolio, was not disclosed in this quarter [1] Foreign Institutional Holdings - No new foreign institutional investors were disclosed in this quarter, with Barclays Bank PLC being the only one not reported in the previous quarter [2]
机构风向标 | 全信股份(300447)2025年三季度已披露前十大机构持股比例合计下跌1.24个百分点
Xin Lang Cai Jing· 2025-10-25 02:58
Core Viewpoint - Quanshin Co., Ltd. (300447.SZ) reported its Q3 2025 financial results, indicating a decline in institutional investor holdings and changes in public fund disclosures [1] Institutional Holdings - As of October 24, 2025, there are 2 institutional investors holding a total of 3.3368 million shares of Quanshin, representing 1.07% of the total share capital [1] - The institutional holding percentage decreased by 1.24 percentage points compared to the previous quarter [1] Public Fund Disclosures - One new public fund was disclosed in this period, namely Changxin National Defense Military Industry Quantitative Mixed A [1] - A total of 80 public funds were not disclosed in this quarter compared to the previous one, including notable funds such as Ping An New Xin Pioneer Mixed A and Invesco Great Wall CSI 300 Index Enhanced A [1]
机构风向标 | 振东制药(300158)2025年三季度已披露持仓机构仅6家
Sou Hu Cai Jing· 2025-10-22 23:37
Core Insights - Zhendong Pharmaceutical (300158.SZ) reported its Q3 2025 financial results, revealing that as of October 22, 2025, six institutional investors held a total of 395 million shares, representing 39.33% of the company's total equity [1] - The institutional ownership increased by 0.41 percentage points compared to the previous quarter [1] - The report also noted the presence of 13 public funds, including notable names such as Invesco Great Wall and Huashang, which did not disclose holdings in the previous quarter [1] Institutional Ownership - Six institutional investors collectively own 39.33% of Zhendong Pharmaceutical's shares, with significant contributions from Shanxi Zhendong Health Industry Group and Hong Kong Central Clearing Limited [1] - The increase in institutional ownership indicates growing confidence in the company among institutional investors [1] Public Fund Activity - A total of 13 public funds were reported, including Invesco Great Wall and Huashang, which are focused on enhancing index performance [1] - This suggests a diversified interest from public funds in Zhendong Pharmaceutical, potentially indicating positive market sentiment [1] Social Security Fund Involvement - One new social security fund, the National Social Security Fund 104 Portfolio, disclosed its holdings in Zhendong Pharmaceutical during this reporting period [1] - This addition reflects the interest of social security funds in the company's performance and stability [1] Foreign Investment Trends - Foreign investment increased with Hong Kong Central Clearing Limited raising its stake by 2.93% compared to the previous period [1] - This uptick in foreign investment may signal a favorable outlook for Zhendong Pharmaceutical in the international market [1]